Icon (ICLR) EBITDA Margin (2009 - 2026)
Icon's (ICLR) quarterly EBITDA Margin came in at 15.86% in Q2 2026, down 463.0% year-over-year from 4.37% in Q2 2025, and up 85.67% quarter-over-quarter from 8.54% in Q1 2026.
Analysis
Icon (ICLR) EBITDA Margin (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported EBITDA Margin for 18 consecutive years, with 15.86% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 463.0% year-over-year to 15.86% in Q2 2026; TTM through Jun 2026 was 13.4%, a 686.0% decrease from a year earlier, with the FY2025 full-year figure at 14.15%, down 704.0% from the prior year.
- EBITDA Margin was 15.86% for Q2 2026 at Icon, up from 8.54% in the prior quarter.
- Over five years, EBITDA Margin peaked at 21.24% in Q2 2024 and troughed at 8.54% in Q1 2026.
- A 5-year average of 18.59% and a median of 19.89% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 300 bps in 2022 and tumbled 1084 bps in 2026, its largest moves.
- Over 5 years, EBITDA Margin stood at 20.64% in 2022, then increased by 1 bps to 20.88% in 2023, then dropped by 2 bps to 20.49% in 2024, then plunged by 52 bps to 9.84% in 2025, then surged by 61 bps to 15.86% in 2026.
- The last three EBITDA Margin figures came in at 15.86% (Q2 2026), 8.54% (Q1 2026), and 9.84% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 21.68% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 15.86% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.86% |
| Mar 31, 2026 | 8.54% |
| Dec 31, 2025 | 9.84% |
| Sep 30, 2025 | 19.42% |
| Jun 30, 2025 | 20.49% |
| Mar 31, 2025 | 19.38% |
| Dec 31, 2024 | 20.49% |
| Sep 30, 2024 | 20.63% |
| Jun 30, 2024 | 21.24% |
| Mar 31, 2024 | 21.24% |
| Dec 31, 2023 | 20.88% |
| Sep 30, 2023 | 20.49% |
| Jun 30, 2023 | 20.06% |
| Mar 31, 2023 | 19.71% |
| Dec 31, 2022 | 20.64% |
| Sep 30, 2022 | 19.54% |
| Jun 30, 2022 | 18.31% |
| Mar 31, 2022 | 17.91% |
| Dec 31, 2021 | 17.64% |
| Sep 30, 2021 | 17.41% |